Owner Sonus Pharmaceuticals, Inc.

Inventors Zhang, Yuehua; Gold, Lynn C.

Agent FB Rice

Pub. Number AU-B-2004285037

PCT Pub. Number WO2005/042539

Priority 60/556,137 24.03.04 US; 60/621,655 26.10.04 US; 60/515,364 29.10.03 US; 60/558,762 01.04.04 US

Filing date 29 October 2004

Wipo publication date 12 May 2005

Acceptance publication date 22 July 2010

C07D 311/72 (2006.01) Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings

A61K 9/107 (2006.01) Medicinal preparations characterised by special physical form - Emulsions

A61K 31/337 (2006.01) - having four-membered rings, e.g. taxol

A61K 31/355 (2006.01)

A61K 31/4745 (2006.01)

A61K 47/22 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Heterocyclic compounds

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

C07D 407/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

C07D 491/22 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

C07H 15/252 (2006.01) Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals